我要投票 普济堂在乌鸡白凤丸行业中的票数:1340
· 外 推 电 报 ·
2026-07-17 14:36:20 星期五

【普济堂是哪个国家的品牌?】

普济堂是什么牌子?「普济堂」是 药都制药集团股份有限公司 旗下著名品牌。该品牌发源于河北省保定市,由创始人李董在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力普济堂品牌出海!将品牌入驻外推网,定制普济堂品牌推广信息,可以显著提高普济堂产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

始建于1993年,以中成药生产/中药材提取为主,兼营中药材标准化种植/中药研究开发为一体的民营集团企业


药都制药集团股份有限公司始建于1993年,注册地址河北省安国市,是一家以中成药为主,中药研究开发为一体的民营集团企业。公司位于安国市东方药城,占地5.5万平方米,建筑面积5万平方米。主要生产丸剂、片剂、胶囊剂等十二个剂型317个品种,其中以蜜丸系列为主导产品,远销全国各地,畅销品种有止嗽立效片、血府逐瘀丸、感冒灵颗粒(无糖型)等。公司产品中药剂型品种齐全,是国家基本药物主要生产厂家。

公司与大专院校和科研院所建立稳定的合作关系,积极开展自主创新活动,已经获得16项发明专利,取得各类专利37项,拥有小蜜丸产品36个,芪黄颗粒荣获国家中药六类新药证书。

药都集团二十多年的发展已在中药发展史上写下了辉煌的篇章,“弘扬国药文化,造就药都精品,专注于中药现代化、国际化、科学化”的发展目标和“精益求精创好药、精打细算降消耗、 精兵强将促销售、精心管理增效益”的工作方针以及“以人为本、科学发展”、“ 品质好、疗效好”等企业文化,增强了企业在市场条件下的竞争力和自我发展能力,促进了企业的发展。


英文翻译:Founded in 1993, Yaodu Pharmaceutical Group Co., Ltd., a private group enterprise mainly engaged in the production of proprietary Chinese medicine / extraction of traditional Chinese medicine, and also engaged in the standardized cultivation of traditional Chinese medicine / research and development of traditional Chinese medicine, was founded in 1993 with its registered address in Anguo City, Hebei Province. It is a private group enterprise mainly engaged in proprietary Chinese medicine and research and development of traditional Chinese medicine. The company is located in Oriental pharmaceutical City, Anguo City, covering an area of 55000 square meters and a building area of 50000 square meters. It mainly produces 317 varieties of 12 dosage forms such as pill, tablet and capsule, among which honey pill series are the leading products, which are sold all over the country, and the best-selling varieties include Zhisoulixiao tablet, Xuefu Zhuyu pill, Ganmaoling granule (sugar free type), etc. The company has a complete range of traditional Chinese medicine dosage forms and is the main manufacturer of national essential drugs. The company has established a stable cooperative relationship with colleges and universities and scientific research institutes, actively carried out independent innovation activities, and has obtained 16 invention patents, 37 patents of various types, 36 Xiaomi pills, and Qihuang granules have won the national six class new drug certificate of traditional Chinese medicine. The development of Yaodu group in the past 20 years has written a brilliant chapter in the development history of traditional Chinese medicine, which includes the development goal of "carrying forward the national medicine culture, creating the excellent medicine capital, focusing on the modernization, internationalization and scientificization of traditional Chinese medicine", the working principle of "striving for perfection, creating good medicine, calculating carefully, reducing consumption, strengthening the sales, managing meticulously and increasing benefit", and the working principle of "people-oriented and scientific development" ”The corporate culture of "good quality, good effect" enhances the competitiveness and self-development ability of the enterprise under the market conditions, and promotes the development of the enterprise.

本文链接: https://www.waitui.com/brand/819ffc37f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

曙光8000亮相WAIC 2026,单个计算单元算力密度提升20倍

36氪获悉,7月17日,曙光8000(登峰)在2026世界人工智能大会以真机形态首次公开亮相,入选大会“镇馆之宝”。该系统采用超智融合架构,支持FP64至INT8全精度计算,单个计算单元算力密度提升20倍;自研scaleFabric互连技术可支撑十万卡规模稳定互连。系统已完成300余项重点应用适配,覆盖20余个科研与产业领域。

37分钟前

创业板指跌超7%,三市下跌个股近5000只

36氪获悉,指数走弱,创业板指下挫跌超7%,沪指跌2.69%,深成指跌5.30%。算力硬件、半导体芯片、医药医疗、贵金属、游戏传媒等方向跌幅居前,沪深京三市下跌个股近5000只,其中近660股跌超9%。

37分钟前

英特尔与Google Cloud宣布深化战略合作

英特尔与Google Cloud宣布深化双方多年战略合作,通过部署Gemini Enterprise和Google Cloud,加速英特尔全公司范围的数字化转型。英特尔计划将Gemini驱动的先进生成式AI应用于全球员工日常工作,帮助其扩展各项能力,并强化工程、供应链及企业运营领域的工作流。Google Cloud高度可扩展的基础设施还将增强英特尔的半导体开发环境,引入定制化的智能体工作流,缩短芯片设计周期,提升跨部门协同效率。(界面)

37分钟前

蜂巢能源发布蜂行短刀3.0等全场景新品

36氪获悉,7月16日,蜂巢能源举行全球合作伙伴峰会。会上,蜂巢能源发布了蜂行短刀3.0、混合固液6C超充电芯、全新大电量磷酸铁锂HEV电池包等一系列覆盖动力、储能及新兴市场的全场景新品,并宣布飞叠4.0将于年内量产交付,凭借16片同时叠技术,叠片效率实现翻倍。

37分钟前

沪深两市成交额突破2万亿

36氪获悉,沪深两市成交额突破2万亿,较上一个交易日此时放量超2100亿元。

37分钟前

本页详细列出关于普济堂的品牌信息,含品牌所属公司介绍,普济堂所处行业的品牌地位及优势。
咨询